* Liver function: Bilirubin \<= 1.5 X ULN; Alkaline phosphatase \<= 5 x ULN; AST and ALT \<= 1.5 x ULN.
* Renal function:serum creatinine \<= 2mg/dL.
You may not be if
Prior systemic chemotherapy for advanced disease.
Prior radiotherapy for NSCLC.
Patients with symptomatic brain metastases.
No measurable bone metastases or malignant pleural effusion as only measurable lesion.
History of prior malignancies, except curatively treated in situ carcinoma of the cervix or other cancer curatively treated and with no evidence of disease for at least five years.
History of hypersensitivity reaction study drugs.
Pregnant or lactating women (women of childbearing potential must use adequate contraception).
Concurrent treatment with other experimental drugs.
Current peripheral neuropathy NCI grade 2.
Participation in clinical trials within 30 days of study entry.
Major surgery, open biopsy or traumatic lesion 28 days before to study start.
Clareo Health | Biweekly Gemcitabine and Docetaxel as First Line Therapy for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients
